Skip Nav Destination
Issues
1 March 2018
-
Cover Image
Cover Image
ABOUT THE COVER
In this issue, a study by Brückmann and colleagues (beginning on page 417) demonstrates a novel epigenetic perturbation specific to premalignant and malignant cells. They show that chromosome 1q12 pericentromeric satellite DNA is epigenetically reprogrammed into a polycomb state forming subnuclear domains called polycomb bodies. The cover image shows the chromatin-associated distribution of polycomb protein BMI1 in the gallbladder, as it occurs in non-malignant tissues. This shift in epigenetic regulation of 1q12 satellite DNA presented by the authors may be used as an early diagnostic marker or new therapeutic target. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Cell Cycle and Senescence
Cell Death and Survival
Chromatin, Epigenetics, and RNA Regulation
Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients
Margarita González-Vallinas; Manuel Rodríguez-Paredes; Marco Albrecht; Carsten Sticht; Damian Stichel; Julian Gutekunst; Adriana Pitea; Steffen Sass; Francisco J. Sánchez-Rivera; Justo Lorenzo-Bermejo; Jennifer Schmitt; Carolina De La Torre; Arne Warth; Fabian J. Theis; Nikola S. Müller; Norbert Gretz; Thomas Muley; Michael Meister; Darjus F. Tschaharganeh; Peter Schirmacher; Franziska Matthäus; Kai Breuhahn
DNA Damage and Repair
Metabolism
Author Choice
Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-13C] Lactate
Sui Seng Tee; Izabela Suster; Steven Truong; Sangmoo Jeong; Roozbeh Eskandari; Valentina DiGialleonardo; Julio A. Alvarez; Hannah N. Aldeborgh; Kayvan R. Keshari
Genomics
Novel Intergenically Spliced Chimera, NFATC3-PLA2G15, Is Associated with Aggressive T-ALL Biology and Outcome
Jonathan Bond; Christine Tran Quang; Guillaume Hypolite; Mohamed Belhocine; Aurélie Bergon; Gaëlle Cordonnier; Jacques Ghysdael; Elizabeth Macintyre; Nicolas Boissel; Salvatore Spicuglia; Vahid Asnafi
Oncogenes and Tumor Suppressors
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Daniel Benten; Yasmin Behrang; Ludmilla Unrau; Victoria Weissmann; Gerrit Wolters-Eisfeld; Susanne Burdak-Rothkamm; Felix R. Stahl; Martin Anlauf; Patricia Grabowski; Markus Möbs; Jan Dieckhoff; Bence Sipos; Martina Fahl; Corinna Eggers; Daniel Perez; Maximillian Bockhorn; Jakob R. Izbicki; Ansgar W. Lohse; Jörg Schrader
Signal Transduction
Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis
Shuhei Enjoji; Ryotaro Yabe; Shunya Tsuji; Kazuhiro Yoshimura; Hideyoshi Kawasaki; Masashi Sakurai; Yusuke Sakai; Hiroko Takenouchi; Shigefumi Yoshino; Shoichi Hazama; Hiroaki Nagano; Hiroko Oshima; Masanobu Oshima; Michael P. Vitek; Tetsuya Matsuura; Yoshitaka Hippo; Tatsuya Usui; Takashi Ohama; Koichi Sato
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.